Position in GILD
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$7,747,042
-$801,635 QoQ
Shares Held
61,319
-0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
2.27%
of 13F equity value
Holder Rank
#481
of 2,266 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AIMZ Investment Advisors, LLC holds $37,637,360 across 11 Drug Manufacturers - General names. GILD ranks #1 (20.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
This page
|
61,319 | $7,747,042 | |
| 2 | AZN |
Astrazeneca PLC
|
27,221 | $5,161,646 | |
| 3 | AMGN |
Amgen Inc
|
12,935 | $4,684,022 | |
| 4 | ABBV |
AbbVie Inc.
|
15,376 | $3,869,216 | |
| 5 | JNJ |
Johnson & Johnson
|
13,954 | $3,543,897 | |
| 6 | MRK |
Merck & Co., Inc.
|
25,475 | $3,273,537 | |
| 7 | GSK |
GSK plc
|
59,214 | $3,103,997 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
52,522 | $3,026,317 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,747,042 | 61,319 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,548,677 | 61,338 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $7,835,353 | 63,837 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $7,118,430 | 64,130 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $7,208,767 | 65,020 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,448,635 | 66,476 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $6,187,958 | 66,991 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $5,657,523 | 67,480 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $4,656,080 | 67,863 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $5,010,226 | 68,399 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $5,625,010 | 69,436 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $5,281,321 | 70,474 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $5,451,700 | 70,737 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $5,897,009 | 71,074 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $6,197,769 | 72,193 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $4,530,081 | 73,433 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $4,574,496 | 74,009 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $4,413,865 | 74,245 | Shares | Sole | 2022-05-06 | |
| 2021-12-31 | $5,084,950 | 70,031 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $4,803,514 | 68,769 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $4,714,362 | 68,463 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $4,422,372 | 68,426 | Shares | Sole | 2021-04-28 | |
| 2020-12-31 | $3,995,354 | 68,578 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $3,611,814 | 57,158 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,438,053 | 57,682 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $4,275,898 | 57,195 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||